Home > Boards > US Listed > Biotechs > Voyager Therapeutics Inc (VYGR)

OBVIOUSLY MANAGEMENT IS PLEASANTLY SURPRISED BY

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Sam Dan Member Profile
Member Level 
Followed By 23
Posts 3,706
Boards Moderated 0
Alias Born 01/02/03
160x600 placeholder
Voyager Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 9/2/2021 5:08:39 PM
Voyager Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 8/10/2021 4:20:01 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2021 7:39:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/9/2021 7:11:07 AM
Voyager Therapeutics Transforms Pipeline and Increases Investment in Next-Generation TRACER™ AAV Capsid and Vectorized Antibody Platform Technologies GlobeNewswire Inc. - 8/9/2021 7:00:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 7/12/2021 8:32:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/8/2021 4:10:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/8/2021 4:07:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2021 4:35:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2021 4:34:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2021 4:33:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2021 4:32:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/25/2021 4:32:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/19/2021 4:57:49 PM
Voyager Therapeutics announces strategic shift and CEO transition Seeking Alpha - 5/19/2021 4:08:16 PM
Voyager Therapeutics Announces Strategic Shift and Leadership Transitions GlobeNewswire Inc. - 5/19/2021 4:01:00 PM
Voyager Therapeutics Presents New Preclinical Data Showing Reduction of Pathological Tau with Vectorized Anti-Tau Antibody GlobeNewswire Inc. - 5/12/2021 7:30:00 AM
Voyager Therapeutics’ AAV capsids show encouraging action in non-human primates Seeking Alpha - 5/11/2021 8:05:48 AM
Voyager Therapeutics’ Novel Capsids Demonstrate Robust Delivery Across the Blood Brain Barrier, Widespread CNS Transduction... GlobeNewswire Inc. - 5/11/2021 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2021 8:29:17 AM
Voyager Therapeutics EPS in-line, misses on revenue Seeking Alpha - 5/10/2021 7:57:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2021 7:44:09 AM
Voyager Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates GlobeNewswire Inc. - 5/10/2021 7:30:00 AM
Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy Virtual 2021 Annu... GlobeNewswire Inc. - 4/28/2021 8:00:00 AM
Voyager shares rise as FDA lifts clinical hold on Huntington’s disease treatment IND Seeking Alpha - 4/26/2021 8:21:48 AM
Sam Dan Member Level  Friday, 02/05/21 09:25:01 AM
Re: None
Post # of 24 
OBVIOUSLY MANAGEMENT IS PLEASANTLY SURPRISED BY THE MAJOR INCREASE IN TRANSACTIONS since Jan 1. IT INDICATES THEY ARE DOING SOMETHING RIGHT. HOPEFULLY, IT WILL CONTINUE
"Voyager Digital Ltd. has provided stakeholders with an update for the following key metrics for the month ended January, 2021, and for the period Feb. 1, 2021, to Feb. 4, 2021.

- Revenue Exceeds US$8.5 Million for the Month of January 2021 and Exceeds US$2.5 Million for the period February 1 to February 4, 2021 -

- Assets Under Management Surpass US$800 Million as of February 4, 2021 -

Preliminary revenue from operations was approximately US$8.5 million for the month of January 2021, up from US$1.7 million in the month of December, 2020. Preliminary revenue from operations for the period February 1, 2021 to February 4, 2021 is estimated to be at approximately US$2.5 million.

Net cash deposits were approximately US$120 million for the month of January, 2021, up from approximately US$30 million for the month of December, 2020. Net cash deposits were approximately US$18 million for the period February 1, 2021 to February 4, 2021.

Assets Under Management (AUM) were approximately US$800 million as of February 4, 2021, up from US$230 million at December 31, 2020, mainly attributable to both the increased in the value of held assets and the net cash deposited on the platform for the period.

Trades per day averaged more than 30,000 for the month ended January 31, 2021, up from an average of approximately 6,500, in December, 2020. Trades per day for the period February 1, 2021 to February 4, 2021 averaged 60,000 trades per day.

New funded accounts were 65,000 for the month of January, 2021, with total funded accounts over 106,000 as of February 4, 2021.

Basic Users on the platform were approximately 440,000 as of February 4, 2021 up from 150,000 as of December 31, 2020.

The value of customer trades for January increased over 5x to US$840 million up from US$150 million in December, 2020. The Company has executed over US$170 million of trades for the period February 1 through February 4, 2021.

All figures are preliminary and unaudited and subject to final adjustment. All amounts are in US dollars, unless otherwise indicated.
"While we believe our recent business metrics reflect the growing interest in the cryptocurrency ecosystem and long-term benefits of our business model, the unprecedented external events over the past week, including decisions made by competitive products, have brought significant upside to our metrics," said Steve Ehrlich, Co-founder and CEO of Voyager. "While we don't expect a repeat of the unprecedented external events of the past few weeks that have served as a catalyst for the recent growth, we anticipate continued meaningful growth in our business, including from the pipeline of approximately 80,000 customers who have signed up and that we are presently onboarding. We remain focused on executing our long-term business plan and expect Voyager will continue to grow the business in a more traditional pattern throughout the balance of 2021. To support this growth, we anticipate increased expenditures in order to materially increase our employee headcount during this period, while also increasing our technology architecture stack in the near-term to accommodate significantly more users."


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences